State UT
Clinical Trials in Utah
Utah is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Utah and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 211 actively recruiting studies with Utah sites out of 211 registered in total. The busiest research areas in Utah are Breast Cancer, Advanced Solid Tumor, Advanced Solid Tumors. Leading sponsors running trials in the state include University of Utah, AstraZeneca, National Cancer Institute (NCI). By stage, Utah trials break down as Phase 1 (43), Phase 2 (64), Phase 3 (63), Phase 4 (9).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Utah
Frequently Asked Questions — Clinical Trials in Utah
How many clinical trials are currently recruiting in Utah?
ClinicalMetric currently tracks 211 actively recruiting clinical trials with at least one location in Utah. The total number of registered studies—including active but not currently enrolling trials—is 211. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Utah?
Utah hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Advanced Solid Tumor, Advanced Solid Tumors, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Utah serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Utah?
To join a clinical trial in Utah, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Utah maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Utah
NCT06613360 Phase 1
Recruiting
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, ...
Condition
SLE
Enrollment
24 pts
Location
United States, Australia, Bulgaria
Sponsor
Cullinan Therapeutics Inc.
NCT06619561 Phase 2
Recruiting
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host ...
Condition
Chronic Graft-Versus-Host Disease (cGVHD)
Enrollment
48 pts
Location
United States
Sponsor
Deciphera Pharmaceuticals, LLC
NCT06624670 Phase 3
Recruiting
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyo...
Condition
Pyoderma Gangrenosum
Enrollment
90 pts
Location
United States, Argentina, Australia
Sponsor
LEO Pharma
NCT05661461 Phase 1
Recruiting
Dose-escalation Study to Assess Safety and Pharmacokinetics of Nab-Sirolimus in ...
Condition
Tumor, Solid
Enrollment
28 pts
Location
United States
Sponsor
Aadi Bioscience, Inc.
NCT06720753 N/A
Recruiting
Real-time Examination of Skills and Coping Use in Teen's Everyday Lives
Condition
Self Injurious Behavior
Enrollment
200 pts
Location
United States
Sponsor
University of Utah
NCT04775745 Phase 1
Recruiting
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B...
Condition
CLL/SLL
Enrollment
60 pts
Location
United States
Sponsor
Newave Pharmaceutical Inc
NCT07717892 Phase 3
Recruiting
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOC...
Condition
ADHD
Enrollment
468 pts
Location
United States
Sponsor
Axsome Therapeutics, Inc.
NCT05519475 Phase 2
Recruiting
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Dise...
Condition
Metabolic Dysfunction-Associated SteatoHepatitis (MASH)
Enrollment
120 pts
Location
United States, Japan, Puerto Rico
Sponsor
Regeneron Pharmaceuticals
NCT06095128 Phase 4
Recruiting
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Condition
Ulcerative Colitis
Enrollment
65 pts
Location
United States, Canada
Sponsor
Takeda
NCT06801002 Phase 1
Recruiting
Trial to Evaluate the Safety & Tolerability of JBZ-001 in Pts With Advanced Soli...
Condition
Solid Tumor
Enrollment
25 pts
Location
United States
Sponsor
Jabez Bioscience, Inc
NCT06708299 Phase 3
Recruiting
CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)
Condition
Recurrent Pericarditis
Enrollment
110 pts
Location
United States, Canada, Greece
Sponsor
Cardiol Therapeutics Inc.
NCT07167927 N/A
Recruiting
Developing an Innovative Decision Support Tool for Pediatric Neuromuscular Scoli...
Condition
Children With Medical Complexity (CMC)
Enrollment
110 pts
Location
United States
Sponsor
University of Utah
NCT06218875 N/A
Recruiting
Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endopros...
Condition
AAA - Abdominal Aortic Aneurysm
Enrollment
2,000 pts
Location
United States, Australia, Austria
Sponsor
W.L.Gore & Associates
NCT06674681 N/A
Recruiting
HPV Self-Collection Program
Condition
HPV
Enrollment
1,000 pts
Location
United States
Sponsor
University of Utah
NCT06975722 Phase 2
Recruiting
A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participant...
Condition
Ulcerative Colitis
Enrollment
99 pts
Location
United States, Australia, China
Sponsor
Sanofi
NCT06283966 Phase 3
Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fum...
Condition
COPD (Chronic Obstructive Pulmonary Disease)
Enrollment
5,000 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT05125302 Phase 3
Recruiting
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets f...
Condition
Migraine
Enrollment
1,059 pts
Location
United States, Puerto Rico
Sponsor
AbbVie
NCT06554795 Phase 1, Phase 2
Recruiting
First-in-human Study of DB-1419 for Advanced/Metastatic Solid Tumors
Condition
Solid Tumor, Adult
Enrollment
360 pts
Location
United States, Australia, China
Sponsor
DualityBio Inc.
NCT07599982 N/A
Recruiting
Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabet...
Condition
Type 1 Diabetes (T1D)
Enrollment
102 pts
Location
United States
Sponsor
DreaMed Diabetes
NCT07684235 Phase 3
Recruiting
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of ...
Condition
Obesity
Enrollment
3,200 pts
Location
United States, Australia, Japan
Sponsor
Amgen
NCT02390518 Phase 1
Recruiting
Stereotactic Radiosurgery Dose Escalation for Brain Metastases
Condition
Brain Metastases
Enrollment
86 pts
Location
United States
Sponsor
University of Utah
NCT05379985 Phase 1, Phase 2
Recruiting
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Muta...
Condition
Non-small Cell Lung Cancer (NSCLC)
Enrollment
754 pts
Location
United States
Sponsor
Revolution Medicines, Inc.
NCT06872125 Phase 3
Recruiting
A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevu...
Condition
Dravet Syndrome
Enrollment
170 pts
Location
United States, China, France
Sponsor
Stoke Therapeutics, Inc
NCT06336655 Phase 2
Recruiting
Physiology of Unloading VA ECMO Trial
Condition
Cardiogenic Shock
Enrollment
104 pts
Location
United States
Sponsor
University of Utah
NCT04910685 Phase 2, Phase 3
Recruiting
(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Pati...
Condition
Indolent Systemic Mastocytosis
Enrollment
534 pts
Location
United States, Argentina, Australia
Sponsor
Blueprint Medicines Corporatio
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology